3 National Diagnostics Network, Dairy Products Company and Printed Cartons and Labels Maker Stocks With a Strong Future Roadmap: Dr. Lal PathLabs, Dodla Dairy and TCPL Packaging

Diagnostics, dairy and carton packaging stocks bring together companies with a visible plan for the years ahead. Dr. Lal PathLabs, Dodla Dairy and TCPL Packaging cover a national diagnostics network, a dairy products company and a printed cartons and labels maker.

This list covers three diagnostics, dairy and carton packaging stocks with complete current figures: Dr. Lal PathLabs, Dodla Dairy and TCPL Packaging. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Diagnostics, Dairy and Carton Packaging Stocks?

Diagnostics, dairy and carton packaging stocks are listed companies that run a national network of laboratories and patient service centres, procure milk and sell value-added dairy products, and make printed folding cartons, laminates and labels for consumer and pharma brands. Their earnings depend on test volumes, dairy demand and packaged goods volumes.

Diagnostics, Dairy and Carton Packaging Stocks at a Glance

On valuation, Dr. Lal PathLabs and Dodla Dairy trade at a P/E below the industry P/E, while TCPL Packaging trades above it, which reflects the growth the market already expects. Readers comparing diagnostics, dairy and carton packaging stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in diagnostics, dairy and carton packaging stocks can use the coming numbers to test whether growth is holding.

Why Do Diagnostics, Dairy and Carton Packaging Stocks Have a Strong Roadmap in India?

Diagnostics, dairy and carton packaging stocks have a strong roadmap in India because growing health awareness, rising demand for packaged dairy and wider use of branded packaging keep widening the market for these companies.

• Diagnostics. More people take regular tests.
• Dairy. Value added milk products reach more homes.
• Packaging. Consumer brands need printed cartons.

Why Dr. Lal PathLabs Features Among These Diagnostics, Dairy and Carton Packaging Stocks

Among the diagnostics, dairy and carton packaging stocks on this list, Dr. Lal PathLabs is one of India's best-known diagnostics companies, operating a national reference laboratory with a hub-and-spoke network of labs, patient service centres and collection points.

The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P/E of 56.6, below the industry P/E of 59.6.

Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore.

Roadmap: Its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.

What to watch: Follow test volumes per patient and the balance between routine and specialised tests.

Why Dodla Dairy Features Among These Diagnostics, Dairy and Carton Packaging Stocks

Among the health, food and packaging shares on this list, Dodla Dairy, based in Hyderabad, procures milk from farmers and sells milk and value-added products such as curd, ghee and ice creams across South and East India, with operations in Africa.

Revenue rose from Rs 2,257 crore in FY22 to Rs 4,186 crore in FY26, a compound annual growth rate of 16.7%. Net profit grew from Rs 133 crore in FY22 to Rs 267 crore in FY26, which works out to a compound annual growth rate of 19.1%.

In the June 2026 quarter, revenue grew 18.3% year on year to Rs 1,212 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,064 crore. The stock trades at a P/E of 24.8, below the industry P/E of 33.9.

Roadmap: The company is growing its value-added products, widening its geographic coverage and adding procurement strength. Value-added dairy brings better margins than plain milk, and a bigger farmer base secures supply.

What to watch: Track milk procurement prices and the growth in value-added products.

Why TCPL Packaging Features Among These Diagnostics, Dairy and Carton Packaging Stocks

Among the three companies on this list, TCPL Packaging makes printed folding cartons, laminates and labels for consumer goods, personal care and pharmaceutical customers. It is a supplier to many leading brands in India and overseas.

In the June 2026 quarter, revenue grew 15.9% year on year to Rs 495 crore, while net profit rose 79.3% to Rs 40.0 crore. Revenue rose from Rs 1,089 crore in FY22 to Rs 1,836 crore in FY26, a compound annual growth rate of 14.0%.

Net profit grew from Rs 46.9 crore in FY22 to Rs 97.8 crore in FY26, which works out to a compound annual growth rate of 20.2%. The company has a return on equity of 13.6%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 3,524 crore. The stock trades at a P/E of 30.5, above the industry P/E of 21.7.

Roadmap: The company is investing in new plants and printing technology to serve brand owners who want quality packaging at scale. Rising packaged consumption supports steady volume growth.

What to watch: Follow capacity additions and the growth of export and pharmaceutical packaging.

Dr. Lal PathLabs vs Dodla Dairy vs TCPL Packaging on Key Financials

The table below sets the three diagnostics, dairy and carton packaging stocks side by side on revenue, profit and margin, using reported figures.

Dr. Lal PathLabs posts the highest return on equity in this group at 20.1%. Dodla Dairy combines the largest FY26 revenue at Rs 4,186 crore with the fastest revenue growth, a 16.7% compound annual rate. A useful habit with diagnostics, dairy and carton packaging stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several pathology network, milk and label stocks instead of one name, which keeps a single result from deciding the outcome.

The June 2026 quarter, the latest reported, gives a fresh read on momentum:

Key Risks to Check Before Investing in Diagnostics, Dairy and Carton Packaging Stocks

Every theme carries risks that deserve a check before any decision. For these diagnostics, dairy and carton packaging stocks, the main points are: Long-term health, food and packaging shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

• Test volumes. Footfall and test mix can vary with seasons.
• Consumer spending. Sales follow festivals, incomes and consumer mood.
• Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter diagnostics, dairy and carton packaging stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Diagnostics, Dairy and Carton Packaging Stocks

Diagnostics, dairy and carton packaging stocks suit investors who prefer to study business strength before price moves. Dr. Lal PathLabs, Dodla Dairy and TCPL Packaging each have a clear plan to grow. Based on the 4 November 2026 close, Dr. Lal PathLabs trades at Rs 2,029.4, Dodla Dairy at Rs 985.95 and TCPL Packaging at Rs 4,525. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these diagnostics, dairy and carton packaging stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track diagnostics, dairy and carton packaging stocks, set price alerts and get research-backed stock ideas.

What are diagnostics, dairy and carton packaging stocks?

Ans. Diagnostics, dairy and carton packaging stocks are listed companies that run a national network of laboratories and patient service centres, procure milk and sell value-added dairy products, and make printed folding cartons, laminates and labels for consumer and pharma brands. Their earnings depend on test volumes, dairy demand and packaged goods volumes. This list looks at three of them, Dr. Lal PathLabs, Dodla Dairy and TCPL Packaging, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.

Which diagnostics, dairy and carton packaging stocks are covered in this list?

Ans. This list covers Dr. Lal PathLabs, Dodla Dairy and TCPL Packaging. Based on the 4 November 2026 close, Dr. Lal PathLabs traded at Rs 2,029.4, Dodla Dairy at Rs 985.95 and TCPL Packaging at Rs 4,525. Their return on equity ranges from 13.6% to 20.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.6% to 16.7%.

Why do diagnostics, dairy and carton packaging stocks have a strong future roadmap in India?

Ans. Diagnostics, dairy and carton packaging stocks have a strong roadmap in India because growing health awareness, rising demand for packaged dairy and wider use of branded packaging keep widening the market for these companies. The main drivers are as follows. Diagnostics. More people take regular tests. Dairy. Value added milk products reach more homes. Packaging. Consumer brands need printed cartons. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Dr. Lal PathLabs performed financially?

Ans. Revenue rose from Rs 2,140 crore in FY22 to Rs 2,864 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 350 crore in FY22 to Rs 510 crore in FY26, which works out to a compound annual growth rate of 9.8%. In the June 2026 quarter, revenue grew 18.9% year on year to Rs 830 crore, while net profit rose 27.2% to Rs 170 crore. The company has a return on equity of 20.1%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 30,949 crore. The stock trades at a P/E of 56.6, below the industry P/E of 59.6. Looking ahead, its asset-light collection network lets the company enter new towns without heavy capital spending. Growth levers include test menu expansion in oncology and genetics, wellness packages and deeper reach in North and East India through franchise and direct collection centres.

How has Dodla Dairy performed financially?

Ans. Revenue rose from Rs 2,257 crore in FY22 to Rs 4,186 crore in FY26, a compound annual growth rate of 16.7%. Net profit grew from Rs 133 crore in FY22 to Rs 267 crore in FY26, which works out to a compound annual growth rate of 19.1%. In the June 2026 quarter, revenue grew 18.3% year on year to Rs 1,212 crore. The company has a return on equity of 15.9%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 6,064 crore. The stock trades at a P/E of 24.8, below the industry P/E of 33.9. Looking ahead, the company is growing its value-added products, widening its geographic coverage and adding procurement strength. Value-added dairy brings better margins than plain milk, and a bigger farmer base secures supply.

How has TCPL Packaging performed financially?

Ans. Revenue rose from Rs 1,089 crore in FY22 to Rs 1,836 crore in FY26, a compound annual growth rate of 14.0%. Net profit grew from Rs 46.9 crore in FY22 to Rs 97.8 crore in FY26, which works out to a compound annual growth rate of 20.2%. In the June 2026 quarter, revenue grew 15.9% year on year to Rs 495 crore, while net profit rose 79.3% to Rs 40.0 crore. The company has a return on equity of 13.6%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 3,524 crore. The stock trades at a P/E of 30.5, above the industry P/E of 21.7. Looking ahead, the company is investing in new plants and printing technology to serve brand owners who want quality packaging at scale. Rising packaged consumption supports steady volume growth.

What risks should investors check before buying diagnostics, dairy and carton packaging stocks?

Ans. Investors should check a few risks before buying diagnostics, dairy and carton packaging stocks. Test volumes. Footfall and test mix can vary with seasons. Consumer spending. Sales follow festivals, incomes and consumer mood. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of diagnostics, dairy and carton packaging stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.